The aim of this study was to systematically assess the published literature pertinent to the efficacy of n-3 fatty acid supplementation in reducing the inflammatory cytokine levels of TNF-a, IL-6, and CRP, in patients with HF. This evidence concerns the gene IL6 and hydrops fetalis.